ABBV vs. ONEQ

Last updated Jun 9, 2026

ABBV (AbbVie Inc.) is a stock, while ONEQ (Fidelity Nasdaq Composite Index ETF) is Large Cap Growth Equities fund tracking the Nasdaq Composite Index. Over the past 10 years, ABBV returned 18.63%/yr vs 19.36%/yr for ONEQ. At a 0.33 correlation, their price movements are largely independent.

Performance

ABBV vs. ONEQ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in AbbVie Inc. (ABBV) and Fidelity Nasdaq Composite Index ETF (ONEQ). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, ABBV achieves a -0.77% return, which is significantly lower than ONEQ's 12.15% return. Both investments have delivered pretty close results over the past 10 years, with ABBV having a 18.63% annualized return and ONEQ not far ahead at 19.36%.

ABBV

• 1D: -1.83%
• 1M: 10.68%
• YTD: -0.77%
• 6M: 1.62%
• 1Y: 21.34%
• 3Y*: 21.59%
• 5Y*: 18.74%
• 10Y*: 18.63%

ONEQ

• 1D: 0.83%
• 1M: -1.13%
• YTD: 12.15%
• 6M: 10.74%
• 1Y: 33.89%
• 3Y*: 26.07%
• 5Y*: 14.42%
• 10Y*: 19.36%

*Multi-year figures are annualized to reflect compound growth (CAGR)

ABBV vs. ONEQ - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
ABBV AbbVie Inc.	-0.77%	33.08%	18.86%	-0.23%	24.01%	32.43%	27.72%	1.47%	-0.96%	60.07%
ONEQ Fidelity Nasdaq Composite Index ETF	12.15%	20.89%	29.30%	45.73%	-32.12%	22.11%	44.87%	38.01%	-3.18%	29.29%

Correlation

The correlation between ABBV and ONEQ is -0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.06
Correlation (3Y) Calculated over the trailing 3-year period	0.03
Correlation (5Y) Calculated over the trailing 5-year period	0.11
Correlation (10Y) Calculated over the trailing 10-year period	0.27
Correlation (All Time) Calculated using the full available price history since Jan 3, 2013	0.33

The correlation between ABBV and ONEQ shifts across timeframes, from -0.06 (1 year) to 0.33 (all time), reflecting how their relationship changes across market environments.

Return for Risk

ABBV vs. ONEQ — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ABBV

ABBV Risk / Return Rank: 66
ABBV Sharpe Ratio Rank: 70
ABBV Sortino Ratio Rank: 64
ABBV Omega Ratio Rank: 62
ABBV Calmar Ratio Rank: 66
ABBV Martin Ratio Rank: 66

ONEQ

ONEQ Risk / Return Rank: 65
ONEQ Sharpe Ratio Rank: 70
ONEQ Sortino Ratio Rank: 65
ONEQ Omega Ratio Rank: 67
ONEQ Calmar Ratio Rank: 60
ONEQ Martin Ratio Rank: 64

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ABBV vs. ONEQ - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for AbbVie Inc. (ABBV) and Fidelity Nasdaq Composite Index ETF (ONEQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ABBV	ONEQ	Difference
Sharpe ratio: Return per unit of total volatility	0.88	2.06	-1.17
Sortino ratio: Return per unit of downside risk	1.37	2.68	-1.31
Omega ratio: Gain probability vs. loss probability	1.17	1.36	-0.19
Calmar ratio: Return relative to maximum drawdown	1.24	2.69	-1.46
Martin ratio: Return relative to average drawdown	2.77	10.57	-7.80
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

ABBV vs. ONEQ - Sharpe Ratio Comparison

The current ABBV Sharpe Ratio is 0.88, which is lower than the ONEQ Sharpe Ratio of 2.06. The chart below compares the historical Sharpe Ratios of ABBV and ONEQ, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	ABBV	ONEQ	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.88	2.06	-1.17
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.82	0.65	+0.17
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.73	0.89	-0.17
Sharpe Ratio (All Time) Calculated using the full available price history	0.74	0.64	+0.10

Drawdowns

ABBV vs. ONEQ - Drawdown Comparison

The maximum ABBV drawdown since its inception was -45.09%, smaller than the maximum ONEQ drawdown of -55.09%. Use the drawdown chart below to compare losses from any high point for ABBV and ONEQ.

Drawdown Indicators

	ABBV	ONEQ	Difference
Max Drawdown Largest peak-to-trough decline	-45.09%	-55.09%	+10.00%
Max Drawdown (1Y) Largest decline over 1 year	-17.32%	-12.64%	-4.68%
Max Drawdown (3Y) Largest decline over 3 years	-20.74%	-24.09%	+3.35%
Max Drawdown (5Y) Largest decline over 5 years	-21.92%	-35.23%	+13.31%
Max Drawdown (10Y) Largest decline over 10 years	-45.09%	-35.23%	-9.86%
Current Drawdown Current decline from peak	-6.55%	-4.27%	-2.28%
Average Drawdown Average peak-to-trough decline	-10.72%	-7.95%	-2.77%
Ulcer Index Depth and duration of drawdowns from previous peaks	7.72%	3.22%	+4.50%

Volatility

ABBV vs. ONEQ - Volatility Comparison

AbbVie Inc. (ABBV) has a higher volatility of 6.39% compared to Fidelity Nasdaq Composite Index ETF (ONEQ) at 5.86%. This indicates that ABBV's price experiences larger fluctuations and is considered to be riskier than ONEQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ABBV	ONEQ	Difference
Volatility (1M) Calculated over the trailing 1-month period	6.39%	5.86%	+0.53%
Volatility (6M) Calculated over the trailing 6-month period	17.89%	12.74%	+5.15%
Volatility (1Y) Calculated over the trailing 1-year period	24.33%	16.58%	+7.75%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	22.91%	22.22%	+0.69%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	25.74%	21.76%	+3.98%

Dividends

ABBV vs. ONEQ - Dividend Comparison

ABBV's dividend yield for the trailing twelve months is around 3.02%, more than ONEQ's 0.69% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
ABBV AbbVie Inc.	3.02%	2.87%	3.49%	3.82%	3.49%	3.84%	4.41%	4.83%	3.89%	2.65%	3.64%	3.41%
ONEQ Fidelity Nasdaq Composite Index ETF	0.69%	0.54%	0.65%	0.71%	0.97%	0.54%	0.71%	2.51%	1.08%	0.84%	1.12%	1.04%

Frequently Asked Questions

Can I hold both ABBV and ONEQ in my portfolio?

ABBV and ONEQ have a correlation of -0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, ABBV or ONEQ?

ABBV has higher volatility (6.39%) compared to ONEQ (5.86%). In terms of maximum drawdown, ABBV dropped -45.09% vs ONEQ's -55.09%.

Which has better risk-adjusted returns?

ONEQ currently has the higher Sharpe Ratio (2.06 vs 0.88), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.